Alina Kerimkulova
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Lipoproteins and Cardiovascular Health, Obesity, Physical Activity, Diet, Diabetes, Cardiovascular Risks, and Lipoproteins, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk(2019)4,829 cited
- → 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death(2022)2,635 cited
- Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))(2019)
- → An association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances(2011)38 cited
- → Roadmap for cardiovascular education across the European Society of Cardiology: inspiring better knowledge and skills, now and for the future(2018)20 cited
- → Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region)(2012)18 cited
- → The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population(2014)16 cited
- → Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205](2019)15 cited
- → Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205](2019)14 cited
- [Association of C677T gene polymorphism of methylenetetrahydrofolate reductase with insulin resistance among Kirghizes].(2011)